← All organizations
Highest phase reached
Phase 3
First clinical trial
Nov 30, 2019Last known activity
Sep 30, 2025
Timeline
2010s
- Jan 1, 2018
InxMed (Shanghai) Co., Ltd.— Founded
Drugs by trial phase (16 distinct, 12 trials)
Phase 3 (4 own, 0 via acquisition)
Phase 2 (10 own, 0 via acquisition)
Phase 1 (2 own, 0 via acquisition)
Indications
Studied for
Recent trials (12)
- NCT07174908Lead sponsorPhase 3Sep 30, 2025
- NCT06030258Lead sponsorPhase 1/Phase 2Oct 30, 2023
- NCT05982522Lead sponsorPhase 1/Phase 2Aug 31, 2023
- NCT05994131Lead sponsorPhase 1/Phase 2Jul 13, 2023
- NCT05827796Lead sponsorPhase 1/Phase 2Dec 8, 2022
- NCT06166836Lead sponsorPhase 1/Phase 2Oct 12, 2022
- NCT05379946CollaboratorPhase 1/Phase 2Sep 30, 2022
- NCT06014528Lead sponsorPhase 2Sep 6, 2022
- NCT05830539Lead sponsorPhase 1/Phase 2Mar 10, 2022
- NCT05551507Lead sponsorPhase 1/Phase 2Jul 27, 2020
- NCT05327231Lead sponsorPhase 1Jul 9, 2020
- NCT04109456Lead sponsorPhase 1Nov 30, 2019
Details
- Founded
- Shanghai, CN Jan 1, 2018
- Last known activity
- Sep 30, 2025